Related references
Note: Only part of the references are listed.A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection
Wataru Akahata et al.
NATURE MEDICINE (2010)
Versatile Virus-Like Particle Carrier for Epitope Based Vaccines
Alain C. Tissot et al.
PLOS ONE (2010)
Subunit interactions in bovine papillomavirus
Matthias Wolf et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Vaccination with multimeric L2 fusion protein and L1 VLP or capsomeres to broaden protection against HPV infection
Subhashini Jagu et al.
VACCINE (2010)
VIPERdb(2): an enhanced and web API enabled relational database for structural virology
Mauricio Carrillo-Tripp et al.
NUCLEIC ACIDS RESEARCH (2009)
Interaction of Cowpea Mosaic Virus (CPMV) Nanoparticles with Antigen Presenting Cells In Vitro and In Vivo
Maria J. Gonzalez et al.
PLOS ONE (2009)
Induction of mucosal and systemic antibody responses against the HIV coreceptor CCR5 upon intramuscular immunization and aerosol delivery of a virus-like particle based vaccine
Zoe Hunter et al.
VACCINE (2009)
Efficient generation of cowpea mosaic virus empty virus-like particles by the proteolytic processing of precursors in insect cells and plants
Keith Saunders et al.
VIROLOGY (2009)
Nanotechnology in vaccine delivery
Laura J. Peek et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
Nasal immunization with a recombinant HIV gp120 and nanoemulsion adjuvant produces th1 polarized responses and neutralizing antibodies to primary HIV type 1 isolates
Anna U. Bielinska et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2008)
Recent insights into the biology and biomedical applications of Flock House virus
P. A. Venter et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Virus-sized vaccine delivery systems
Jean-Pierre Y. Scheerlinck et al.
DRUG DISCOVERY TODAY (2008)
Virus-like particles as a vaccine delivery system - Myths and facts
Polly Roy et al.
HUMAN VACCINES (2008)
Translating innate response into long-lasting antibody response by the intrinsic antigen-adjuvant properties of papaya mosaic virus
Elizabeth Acosta-Ramirez et al.
IMMUNOLOGY (2008)
Immunogenic display of diverse peptides on virus-like particles of RNA phage MS2
David S. Peabody et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
Induction of broad CD4+ and CD8+ T-cell responses and cross-neutralizing antibodies against hepatitis C virus by vaccination with Th1-adjuvanted polypeptides followed by defective alphaviral particles expressing envelope glycoproteins gpE1 and gpE2 and nonstructural proteins 3, 4, and 5
Yinling Lin et al.
JOURNAL OF VIROLOGY (2008)
A Vaccine against Nicotine for Smoking Cessation: A Randomized Controlled Trial
Jacques Cornuz et al.
PLOS ONE (2008)
Pre-Clinical Evaluation of a Novel Nanoemulsion-Based Hepatitis B Mucosal Vaccine
Paul E. Makidon et al.
PLOS ONE (2008)
Inexpensive anti-cysticercosis vaccine:: S3Pvac expressed in heat inactivated M13 filamentous phage proves effective against naturally acquired Taenia solium porcine cysticercosis
Julio Morales et al.
VACCINE (2008)
A novel, killed-virus nasal vaccinia virus vaccine
Anna U. Bielinska et al.
CLINICAL AND VACCINE IMMUNOLOGY (2008)
Novel plant virus-based vaccine induces protective cytotoxic T-lymphocyte-mediated antiviral immunity through dendritic cell maturation
Patrick Lacasse et al.
JOURNAL OF VIROLOGY (2008)
Virus-like particles - universal molecular toolboxes
Christine Ludwig et al.
CURRENT OPINION IN BIOTECHNOLOGY (2007)
Prevention of cancer through immunization:: Prospects and challenges for the 21st century
Ian H. Frazer et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
Cryo-electron microscopy study of bacteriophage T4 displaying antbrax toxin proteins
Andrei Fokine et al.
VIROLOGY (2007)
A viral nanoparticle with dual function as an anthrax antitoxin and vaccine
Darly J. Manayani et al.
PLOS PATHOGENS (2007)
High-resolution electron microscopy of helical specimens:: A fresh look at Tobacco Mosaic Virus
Carsten Sachse et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge
Anna U. Bielinska et al.
INFECTION AND IMMUNITY (2007)
Case-control study of human papillomavirus and oropharyngeal cancer
Gypsyamber D'Souza et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Cucumber mosaic virus as a presentation system for a double hepatitis C virus-derived epitope
M. Nuzzaci et al.
ARCHIVES OF VIROLOGY (2007)
The utility of ISCOMATRIX™ adjuvant for dose reduction of antigen for vaccines requiring antibody responses
Jeff Boyle et al.
VACCINE (2007)
Multicomponent anthrax toxin display and delivery using bacteriophage T4
Sathish B. Shivachandra et al.
VACCINE (2007)
Single epitope mucosal vaccine delivered via immuno-stimulating complexes induces low level of immunity against simian-HIV
Bapi Pahar et al.
VACCINE (2006)
Bacteriophage T4 capsid: A unique platform for efficient surface assembly of macromolecular complexes
Qin Li et al.
JOURNAL OF MOLECULAR BIOLOGY (2006)
Protective immunity induced by phage displayed mitochondrial related peptides of Schistosoma japonicum
Wu Hai-Wei et al.
ACTA TROPICA (2006)
Induction of a protective immune response against viral nervous necrosis in the European sea bass Dicentrarchus labrax by using betanodavirus virus-like particles
R. Thiery et al.
JOURNAL OF VIROLOGY (2006)
Virus-like particles: Passport to immune recognition
Elizabeth V. L. Grgacic et al.
METHODS (2006)
Der p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adults
Thomas M. Kuendig et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
In vitro binding of anthrax protective antigen on bacteriophage T4 capsid surface through Hoc-capsid interactions: A strategy for efficient display of large full-length proteins
SB Shivachandra et al.
VIROLOGY (2006)
Hepatitis A virus: From discovery to vaccines
A Martin et al.
HEPATOLOGY (2006)
Immunoreactivity of HCV/HBV epitopes displayed in an epitope-presenting system
YD Chen et al.
MOLECULAR IMMUNOLOGY (2006)
A modified TMV-based vector facilitates the expression of longer foreign epitopes in tobacco
LB Jiang et al.
VACCINE (2006)
Virus-like particles production in green plants
Luca Santi et al.
METHODS (2006)
Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice
P Pushko et al.
VACCINE (2005)
Expression and immunoreactivity of HCV/HBV epitopes
Xin-Yu Xiong et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Triple layered rotavirus VLP production:: Kinetics of vector replication, mRNA stability and recombinant protein production
HLA Vieira et al.
JOURNAL OF BIOTECHNOLOGY (2005)
Essential elements of the capsid protein for self-assembly into empty virus-like particles of hepatitis E virus
TC Li et al.
JOURNAL OF VIROLOGY (2005)
Frontline:: A therapeutic vaccine for nicotine dependence:: preclinical efficacy, and phase I safety and immunogenicity
P Maurer et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Expression and immunoreactivity of an epitope of HCV in a foreign epitope presenting system
Mei Peng et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Filovirus-like particles as vaccines and discovery tools
Kelly L. Warfield et al.
EXPERT REVIEW OF VACCINES (2005)
Induction of murine mucosal CCR5-reactive antibodies as an anti-human immunodeficiency virus strategy
C Barassi et al.
JOURNAL OF VIROLOGY (2005)
Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial
LL Villa et al.
LANCET ONCOLOGY (2005)
Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections
DL Swenson et al.
VACCINE (2005)
Peptide-based candidate vaccine against respiratory syncytial virus
V Yusibov et al.
VACCINE (2005)
Cowpea mosaic virus-based systems for the production of antigens and antibodies in plants
L Liu et al.
VACCINE (2005)
Immunogenic properties of a chimeric plant virus expressing a hepatitis C virus (HCV)-derived epitope: New prospects for an HCV vaccine
G Piazzolla et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2005)
Virus-like particle (VLP) vaccine conferred complete protection against a lethal influenza virus challenge
JM Galarza et al.
VIRAL IMMUNOLOGY (2005)
Virus-like particles as HIV-1 vaccines
LX Doan et al.
REVIEWS IN MEDICAL VIROLOGY (2005)
Recombinant HIV-1 Pr55gag virus-like particles:: potent stimulators of innate and acquired immune responses
L Deml et al.
MOLECULAR IMMUNOLOGY (2005)
Progress towards the development of a HIV-1 gp41-directed vaccine
GB McGaughey et al.
CURRENT HIV RESEARCH (2004)
Evaluation of genetic immunization adjuvants to improve the effectiveness of a human immunodeficiency virus type 2 (HIV-2) envelope DNA vaccine
CP Locher et al.
DNA AND CELL BIOLOGY (2004)
Immunization with hepatitis C virus-like particles induces humoral and cellular immune responses in nonhuman primates
SH Jeong et al.
JOURNAL OF VIROLOGY (2004)
Phase I testing of a malaria vaccine composed of hepatitis B virus core particles expressing Plasmodium falciparum circumsporozoite epitopes
EH Nardin et al.
INFECTION AND IMMUNITY (2004)
Efficient assembly and release of SARS coronavirus-like particles by a heterologous expression system
E Mortola et al.
FEBS LETTERS (2004)
Ebola virus-like particles protect from lethal Ebola virus infection
KL Warfield et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Expression of foot-and-mouth disease virus epitopes in tobacco by a tobacco mosaic virus-based vector
LG Wu et al.
VACCINE (2003)
Immunogenicity and protective efficacy of rotavirus 2/6-virus-like particles produced by a dual baculovirus expression vector and administered intramuscularly, intranasally, or orally to mice
A Bertolotti-Ciarlet et al.
VACCINE (2003)
Development of immune response that protects mice from viral pneumonitis after a single intranasal immunization with influenza A virus and nanoemulsion
A Myc et al.
VACCINE (2003)
Humoral, mucosal, and cellular immune responses to oral Norwalk virus-like particles in volunteers
CO Tacket et al.
CLINICAL IMMUNOLOGY (2003)
Virus-like particles as immunogens
R Noad et al.
TRENDS IN MICROBIOLOGY (2003)
Pre-clinical immunogenicity and efficacy trial of a recombinant hepatitis E vaccine
RH Purcell et al.
VACCINE (2003)
Immunization with hepatitis C virus-like particles protects mice from recombinant hepatitis C virus-vaccinia infection
K Murata et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Insertion of a foreign sequence on capsid surface loops of human papillomavirus type 16 virus-like particles reduces their capacity to induce neutralizing antibodies and delineates a conformational neutralizing epitope
JR Sadeyen et al.
VIROLOGY (2003)
Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide:: a case report
JAR Nicoll et al.
NATURE MEDICINE (2003)
Encapsulation of peptides in biodegradable microspheres prolongs their MHC class-I presentation by dendritic cells and macrophages in vitro
R Audran et al.
VACCINE (2003)
Cholera toxin induces migration of dendritic cells from the subepithelial dome region to T- and B-cell areas of Peyer's patches
VK Shreedhar et al.
INFECTION AND IMMUNITY (2003)
Inflexal®V a trivalent virosome subunit influenza vaccine:: production
R Mischler et al.
VACCINE (2002)
A modified hepatitis B virus core particle containing multiple epitopes of the Plasmodium falciparum circumsporozoite protein provides a highly immunogenic malaria vaccine in preclinical analyses in rodent and primate hosts
A Birkett et al.
INFECTION AND IMMUNITY (2002)
A controlled trial of a human papillomavirus type 16 vaccine
LA Koutsky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Bacterial strategies for overcoming host innate and adaptive immune responses
MW Hornef et al.
NATURE IMMUNOLOGY (2002)
Recombinant dengue virus type 2 envelope/hepatitis B surface antigen hybrid protein expressed in Pichia pastoris can function as a bivalent immunogen
H Bisht et al.
JOURNAL OF BIOTECHNOLOGY (2002)
Evaluation of human papillomavirus testing in primary screening for cervical abnormalities - Comparison of sensitivity, specificity, and frequency of referral
SL Kulasingam et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Atomic model of the papillomavirus capsid
Y Modis et al.
EMBO JOURNAL (2002)
Chimeric human papilloma virus-simian/human immunodeficiency virus virus-like-particle vaccines: Immunogenicity and protective efficacy in macaques
CJ Dale et al.
VIROLOGY (2002)
RNA bacteriophage capsid-mediated drug delivery and epitope presentation
WL Brown et al.
INTERVIROLOGY (2002)
Characterization of the immune response to canine parvovirus induced by vaccination with chimaeric plant viruses
BL Nicholas et al.
VACCINE (2002)
HIV type 1 Gag virus-like particle budding from spheroplasts of Saccharomyces cerenvisiae
S Sakuragi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Systemic and intestinal antibody secreting cell responses and protection in gnotobiotic pigs immunized orally with attenuated Wa human rotavirus and Wa 2/6-rotavirus-like-particles associated with immuno stimulating complexes
C Iosef et al.
VACCINE (2002)
Chimeric recombinant hepatitis E virus-like particles as an oral vaccine vehicle presenting foreign epitopes
M Niikura et al.
VIROLOGY (2002)
Antibody responses to preS components after immunization of children with low doses of BioHepB
K Madalinski et al.
VACCINE (2001)
Expression and purification of dengue virus type 2 envelope protein as a fusion with hepatitis B surface antigen in Pichia pastoris
H Bisht et al.
PROTEIN EXPRESSION AND PURIFICATION (2001)
Recombinant vaccines for hepatitis E
SU Emerson et al.
TRENDS IN MOLECULAR MEDICINE (2001)
Oral immunization with hepatitis B surface antigen expressed in transgenic plants
QX Kong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Hepatitis C virus-like particles induce virus-specific humoral and cellular immune responses in mice
M Lechmann et al.
HEPATOLOGY (2001)
Intranasal immunisation with influenza-ISCOM induces strong mucosal as well as systemic antibody and cytotoxic T-lymphocyte responses
S Sjölander et al.
VACCINE (2001)
Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins
T Latham et al.
JOURNAL OF VIROLOGY (2001)
Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females
AB Moscicki et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Inactivated recombinant plant virus protects dogs from a lethal challenge with canine parvovirus
JPM Langeveld et al.
VACCINE (2001)
Antibodies against a truncated Staphylococcus aureus fibronectin-binding protein protect against dissemination of infection in the rat
A Rennermalm et al.
VACCINE (2001)
Characterization of hepatitis C virus core-specific immune responses primed in rhesus macaques by a nonclassical ISCOM vaccine
NK Polakos et al.
JOURNAL OF IMMUNOLOGY (2001)
A comparison of oral and parenteral routes for therapeutic vaccination with HSV-2ISCOMs in mice; cytokine profiles, antibody responses and protection
SA Mohamedi et al.
ANTIVIRAL RESEARCH (2001)
Puumala (PUU) hantavirus strain differences and insertion positions in the hepatitis B virus core antigen influence B-cell immunogenicity and protective potential of core-derived particles
D Koletzki et al.
VIROLOGY (2000)
Improving vaccine performance with adjuvants
FR Vogel
CLINICAL INFECTIOUS DISEASES (2000)
Immunization with a chimeric tobacco mosaic virus containing an epitope of outer membrane protein F of Pseudomonas aeruginosa provides protection against challenge with P-aeruginosa
J Staczek et al.
VACCINE (2000)
Share Paper
